Ongoing Revenue Recovery
· Revenue continues to track close to 2019 (pre-pandemic) levels, progressing strongly to anticipated 2022 full year revenue of around £2.7bn:
market cap now £1.3b approx
agree on all points......and surely surely, and bad news is priced in!!
he hopes!!!!!
yes finally seems momentum in right direction
nice looking chart forming too!
They know how to write an RNS dont they!
one of the best stocks out there!
darkcloudcoer
really good post
great advice on investing psyhology
erm...global pandemic
https://www.msn.com/en-gb/health/medical/south-african-doctor-who-raised-alarm-about-omicron-variant-says-symptoms-are-unusual-but-mild/ar-AARczsR?ocid=mailsignout&li=BBoPWjQ
"The first South African doctor to alert the authorities about patients with the omicron variant has told The Telegraph that the symptoms of the new variant are unusual but mild."
"Omicron variant unlikely to lead to 'reboot of pandemic' – director of Oxford Vaccine Group
The director of the Oxford Vaccine Group, which developed the AstraZeneca vaccine, expressed cautious optimism that existing vaccines could be effective at preventing serious disease from the Omicron variant and said it is unlikely to result in a reboot of the pandemic.
Speaking on BBC Radio 4’s Today programme, Prof Sir Andrew Pollard said:
If you look at where most of the mutations are, they are similar to regions of the spike protein that have been seen with other variants so far and that tells you that despite mutations existing in other variants, the vaccines have continued to prevent very severe disease as we’ve moved through Alpha, Beta, Gamma and Delta.
At least from a speculative point of view we have some optimism that the vaccine should still work against this variant for severe disease but really we need to wait several weeks to have that confirmed."
Omicron variant unlikely to lead to 'reboot of pandemic' – director of Oxford Vaccine Group
The director of the Oxford Vaccine Group, which developed the AstraZeneca vaccine, expressed cautious optimism that existing vaccines could be effective at preventing serious disease from the Omicron variant and said it is unlikely to result in a reboot of the pandemic.
Speaking on BBC Radio 4’s Today programme, Prof Sir Andrew Pollard said:
If you look at where most of the mutations are, they are similar to regions of the spike protein that have been seen with other variants so far and that tells you that despite mutations existing in other variants, the vaccines have continued to prevent very severe disease as we’ve moved through Alpha, Beta, Gamma and Delta.
At least from a speculative point of view we have some optimism that the vaccine should still work against this variant for severe disease but really we need to wait several weeks to have that confirmed.
Mike etal
I posted before about my surprise about SNGs low profile and how it hasnt been trumpeted by many avenues.
it goes back to my intitial thoughts - we have an abject government coupled with brexit - if anyone is invested here who voted for both brexit and conservatives then you need your head examining
About time!
How Merck's antiviral pill could change the game for COVID-19
A new drug by Merck significantly reduces the risk of hospitalization and death in people who take it early in the course of their COVID-19 illness, according to the interim results of a major study released today. It is the first oral antiviral found to be effective against this coronavirus.
People who took this drug, called molnupiravir—four pills twice a day for five days—within five days of showing symptoms were about half as likely to be hospitalized as those taking the placebo. They were also less likely to die, with eight deaths in the placebo group reported within a month of treatment and none in those who received the medicine.
@Don
take it easy on me man! we down here! just trying to make some sort of comparison!
Just have to hope for a short squeeze now!
what happened to gamestop earlier this year - results in share price flying higher as the shorters try covering their losses!
im in 316!
we all down here but i feel much safer compared to other stocks.
looking that way unless the worst case scenario doesnt materialise
if u voted tory and brexit u cant complain though]
worse still if ur an anri -vaxxer!
https://shorttracker.co.uk/company/GB0006215205/
short on nex some company
Am i right in saying we have a big presence in USA and the covid situation there is bad especially in republican states
the anti-vaxxer movement/non vaccinated here in the UK hasnt helped too